Document is current
Any future updates will be listed below
-
Authors
Spellicy, Samantha E. https://orcid.org/0000-0001-5648-8816
Kaiser, Erin E.
Bowler, Michael M.
Jurgielewicz, Brian J. https://orcid.org/0000-0001-9900-8077
Webb, Robin L.
West, Franklin D. https://orcid.org/0000-0002-0504-7997
Stice, Steven L. https://orcid.org/0000-0001-5710-5872
-
Funding
Funding for this research was provided by:
National Institutes of Health (1R43NS103596-01)
National Science Foundation (CBET-0939511)
- License Information
-
More Information
Article History
Received: 20 August 2019
Revised: 30 October 2019
Accepted: 31 October 2019
First Online: 6 December 2019
Compliance with Ethical Standards
:
: SLS and RW are stockholders in Aruna Bio. Aruna Bio provided research funding to F.D. W. for the original animal studies. S.L.S. was a part time employee of Aruna Bio during the study. SLS is an inventor on patent US 8,178,089 and US 7,531,354, method of producing feeder cell–free neuroprogenitor cells, by contacting pluripotent stem cells with bFGF and a differentiation protein and assigned University of Georgia Research Foundation and exclusively licensed by Aruna Bio. SLS and RW have a patent pending on neural exosomes, assigned University of Georgia Research Foundation, and exclusively licensed by Aruna Bio. These patents are related to the source of material used in the original study.
: All work performed in this study was done in accordance with and approved by the University of Georgia Institutional Animal Care and Use Committee guidelines. This article does not contain any studies with human participants performed by any of the authors.
